Efficacy of transnasal humidified rapid insufflation ventilatory exchange on painless gastroscopy in obese patients

徐亚杰,尹加林,张勇,谢欣怡,鲍红光,王晓亮
DOI: https://doi.org/10.3760/cma.j.cn131073.20200506.00922
2020-01-01
Abstract:Objective:To evaluate the efficacy of transnasal humidified rapid insufflation ventilatory exchange (THRIVE) on painless gastroscopy in the obese patients.Methods:One hundred male or female patients who needed painless gastroscopy, aged 18-64 yr, of American Society of Anesthesiologists physical status Ⅰ or Ⅱ, with body mass index ≥30 kg/m 2, were divided into 2 groups ( n=50 each) using a random number table method: nasal catheter oxygen inhalation group (group C) and THRIVE group (group T). In group C, the pure oxygen was inhaled through the nasal catheter for 8 L/min, while oxygen at concentration of 100% was inhaled via the THRIVE device in group T. After the loading dose of propofol 1.5-2.5 mg/kg was given, pure oxygen 8 L/min was inhaled through the nasal catheter in group C, and the flow rate of oxygen was adjusted to 70 L/min in group T, and then endoscopic operation was started.Propofol 0.2-0.5 mg/kg was intravenously injected each time according to the patient′s physical signs, such as deepening of breathing, increased heart rate, and even body movement.The time for gastroscopy, total consumption of propofol and emergence time were recorded.Adverse events (airway injury or pulmonary barotrauma) related to ventilation were recorded within 5 and 30 min after operation in group T. The occurrence of adverse events related to hypoxia (subclinical respiratory depression, hypoxia and severe hypoxia) and use of treatment measures of adverse events (increasing ventilation oxygen flow, opening airway, mask-assisted ventilation and ventilation after tracheal intubation) were recorded.The subjective scores of patients, operators and anesthesiologists were recorded.The adverse events, including body movement, vomiting, reflux, bronchospasm and bucking were recorded during the examination. Results:Compared with group C, the time for gastroscopy was sginificantly shortened, the consumption of propofol was increased, the incidence of subclinical respiratory depression and hypoxia was decreased, the requirement for opening airway and mask-assisted ventilation was decreased, and the body movement and bucking were decreased in group T ( P<0.05). No ventilation-related adverse events occurred after operation in group T. Conclusion:THRIVE can be safely and effectively used for painless gastroscopy in obese patients.
What problem does this paper attempt to address?